Description
Inosita 50mg tablets are an oral medication prescribed for the effective management of Type 2 Diabetes Mellitus. Containing the active ingredient Sitagliptin, this medicine works by inhibiting the DPP-4 enzyme, which plays a crucial role in regulating blood glucose levels. By increasing the body’s natural incretin hormones, Sitagliptin enhances insulin release and decreases glucagon levels in a glucose-dependent manner. This innovative mechanism helps to lower blood sugar without the significant risk of hypoglycemia, making it a valuable part of a comprehensive diabetes treatment plan alongside diet and exercise. Inosita 50mg is suitable for use alone or in combination with other antidiabetic drugs under a doctor’s supervision.
